Independent Validation of a Prognostic Genomic Signature (ColoPrint) for Patients With Stage II Colon Cancer

Colon Cancer

(2017) Paul F. Engstrom et al.   Journal of the National Comprehensive Cancer Network

Prediction of Prognosis Is Not Improved by the Seventh and Latest Edition of the TNM Classification for Colorectal Cancer in a Single-Center Collective

(2011) Ulrich Nitsche et al.   ANNALS OF SURGERY

Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features

(2011) Erin S. O'Connor et al.   JOURNAL OF CLINICAL ONCOLOGY

DNA Microarrays Are Predictive of Cancer Prognosis: A Re-evaluation

(2010) X. Fan et al.   CLINICAL CANCER RESEARCH

Microsatellite Instability in Colorectal Cancer

(2010) C. Richard Boland et al.   GASTROENTEROLOGY

Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin

(2010) Michael J. O'Connell et al.   JOURNAL OF CLINICAL ONCOLOGY

Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer

(2010) Ramon Salazar et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

(2009) R. N. Jorissen et al.   CLINICAL CANCER RESEARCH

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

(2009) Arnaud D. Roth et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognosis of Patients With Colorectal Cancer Is Associated With Lymph Node Ratio

(2008) Robert Rosenberg et al.   ANNALS OF SURGERY

Development of a Clinically Feasible Molecular Assay to Predict Recurrence of Stage II Colon Cancer

(2008) Yuqiu Jiang et al.   JOURNAL OF MOLECULAR DIAGNOSTICS